Tolerability and efficacy of ruxolitinib in Korean patients with myelofibrosis and incidence of TB lymphadenitis during treatment.
Phase of Trial: Phase IV
Latest Information Update: 17 Sep 2014
At a glance
- Drugs Ruxolitinib (Primary)
- Indications Myelofibrosis
- Focus Adverse reactions; Therapeutic Use
- 17 Sep 2014 New trial record